Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review

Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
52
Medical Devices
Denmark

Coloplast AS (COLO B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coloplast A/S (Coloplast) is a medical device company. It offers products and services in the field of ostomy care, urology, and continence care and wound care. The major products of the company include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; dressings for infected, non-infected and painful wounds; cleansers; moisturisers; skin protectants; antifungals; and hand cleansers. It also offers a wide range of disposable products to support endourologic and percutaneous procedures, prostrate disorders, laproscopic procedures, and testicular prosthesis.

Coloplast AS Key Recent Developments

Oct 31, 2014 Danish medical company Coloplast delivers strong full-year results and expects high future growth.
Aug 13, 2014 Coloplast Delivers On Ambitious Targets With Solid Interim Report
May 07, 2014 Coloplast Raises Guidance For Full-Year Growth
May 02, 2014 Coloplast makes provisions for DKK 1bn for litigation in the USA

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
Coloplast A/S – Key Facts 6
Coloplast A/S – Key Employees 7
Coloplast A/S – Key Employee Biographies 8
Coloplast A/S – Major Products and Services 9
Coloplast A/S – History 11
Coloplast A/S – Company Statement 15
Coloplast A/S – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Coloplast A/S – Key Manufacturing Facilities 19
Section 2 – Company Analysis 20
Coloplast A/S – Business Description 20
Business Description – Continence Care Business 20
Continence Care Business – Overview 20
Continence Care Business – Financials 20
Continence Care Business – Market View 20
Business Description – Ostomy Care Business 20
Ostomy Care Business – Overview 20
Ostomy Care Business – Financials 21
Ostomy Care Business – Market View 21
Business Description – Urology Business 21
Urology Business – Overview 21
Urology Business – Financials 21
Urology Business – Market View 21
Business Description – Wound and Skin Care Business 21
Wound and Skin Care Business – Overview 21
Wound and Skin Care Business – Financials 21
Wound and Skin Care Business – Market View 22
Coloplast A/S – Corporate Strategy 23
Coloplast A/S – SWOT Analysis 24
SWOT Analysis – Overview 24
Coloplast A/S – Strengths 24
Strength – Strategic Acquisitions 24
Strength – Focused Research and Development Activities 24
Strength – Leading Market Position 24
Coloplast A/S – Weaknesses 25
Weakness – Declining Cash Reserves 25
Weakness – Safety Issues/Product Defects 25
Coloplast A/S – Opportunities 26
Opportunity – Global Wound Care Management Market 26
Opportunity – Growing Incontinence Devices Market 26
Opportunity – Negative Pressure Wound Therapy Devices Market 26
Opportunity – The US FDA 510(k) Clearances 26
Coloplast A/S – Threats 27
Threat – Rapid Technological Changes 27
Threat – Stiff Competition 27
Threat – Stringent Government Regulations 27
Coloplast A/S – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 32
Financial Performance 32
Financial Ratios – Interim Ratios 33
Financial Ratios – Ratio Charts 34
Section 4 – Company’s Lifesciences Financial Deals and Alliances 35
Coloplast A/S, Medical Equipment, Deals By Year, 2009 to YTD 2015 35
Coloplast A/S, Medical Equipment, Deals By Type, 2009 to YTD 2015 36
Coloplast A/S, Recent Deals Summary 37
Section 5 – Company’s Recent Developments 38
Mar 02, 2015: Coloplast wins design awards 38
Jan 29, 2015: Coloplast delivers stable growth in first quarter, but lowers its full-year sales growth guidance 39
Jan 13, 2015: 96 Percent of Surveyed Clinicians Recommend Coloplast SenSura Mio For Hospital Use; Report Improved Patient Experience, Body Fit 40
Oct 31, 2014: Danish medical company Coloplast delivers strong full-year results and expects high future growth. 41
Oct 30, 2014: Coloplast Delivers Strong Full-Year Results And Expects High Future Growth 42
Aug 13, 2014: Coloplast Delivers On Ambitious Targets With Solid Interim Report 43
Jul 30, 2014: Coloplast to create 150 jobs 44
Jun 24, 2014: Coloplast strengthens Executive Management 45
May 07, 2014: Coloplast Raises Guidance For Full-Year Growth 46
May 02, 2014: Coloplast makes provisions for DKK 1bn for litigation in the USA 47
Section 6 – Appendix 48
Methodology 48
Ratio Definitions 48
About GlobalData 52
Contact Us 52
Disclaimer 52



List of Tables
Coloplast A/S, Key Facts 6
Coloplast A/S, Key Employees 7
Coloplast A/S, Key Employee Biographies 8
Coloplast A/S, Major Products and Services 9
Coloplast A/S, History 11
Coloplast A/S, Other Locations 17
Coloplast A/S, Subsidiaries 17
Coloplast A/S, Key Manufacturing Facilities 19
Coloplast A/S, Key Competitors 28
Coloplast A/S, Ratios based on current share price 29
Coloplast A/S, Annual Ratios 30
Coloplast A/S, Interim Ratios 33
Coloplast A/S, Medical Equipment, Deals By Year, 2009 to YTD 2015 35
Coloplast A/S, Medical Equipment, Deals By Type, 2009 to YTD 2015 36
Coloplast A/S, Recent Deals Summary 37
Currency Codes 48
Capital Market Ratios 48
Equity Ratios 49
Profitability Ratios 49
Cost Ratios 50
Liquidity Ratios 50
Leverage Ratios 51
Efficiency Ratios 51



List of Figures
Coloplast A/S, Performance Chart (2010 – 2014) 32
Coloplast A/S, Ratio Charts 34
Coloplast A/S, Medical Equipment, Deals By Year, 2009 to YTD 2015 35
Coloplast A/S, Medical Equipment, Deals by Type, 2009 to YTD 2015 36

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.